Structural Plasticity of the Semliki Forest Virus Glycome upon Interspecies Transmission by Crispin, Max et al.
Structural Plasticity of the Semliki Forest Virus Glycome upon
Interspecies Transmission
Max Crispin,*,† David J. Harvey,† David Bitto,‡ Camille Bonomelli,† Matthew Edgeworth,§
James H. Scrivens,§ Juha T. Huiskonen,‡ and Thomas A. Bowden*,‡
†Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United
Kingdom
‡Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3
7BN, United Kingdom
§School of Life Sciences, University of Warwick, Gibbet Hill Road, Coventry CV4 7AL, United Kingdom
ABSTRACT: Cross-species viral transmission subjects parent
and progeny alphaviruses to diﬀerential post-translational
processing of viral envelope glycoproteins. Alphavirus bio-
genesis has been extensively studied, and the Semliki Forest
virus E1 and E2 glycoproteins have been shown to exhibit
diﬀering degrees of processing of N-linked glycans. However
the composition of these glycans, including that arising from
diﬀerent host cells, has not been determined. Here we
determined the chemical composition of the glycans from the
prototypic alphavirus, Semliki Forest virus, propagated in both
arthropod and rodent cell lines, by using ion-mobility mass
spectrometry and collision-induced dissociation analysis. We
observe that both the membrane-proximal E1 fusion
glycoprotein and the protruding E2 attachment glycoprotein display heterogeneous glycosylation that contains N-linked
glycans exhibiting both limited and extensive processing. However, E1 contained predominantly highly processed glycans
dependent on the host cell, with rodent and mosquito-derived E1 exhibiting complex-type and paucimannose-type glycosylation,
respectively. In contrast, the protruding E2 attachment glycoprotein primarily contained conserved under-processed
oligomannose-type structures when produced in both rodent and mosquito cell lines. It is likely that glycan processing of E2
is structurally restricted by steric-hindrance imposed by local viral protein structure. This contrasts E1, which presents glycans
characteristic of the host cell and is accessible to enzymes. We integrated our ﬁndings with previous cryo-electron microscopy
and crystallographic analyses to produce a detailed model of the glycosylated mature virion surface. Taken together, these data
reveal the degree to which virally encoded protein structure and cellular processing enzymes shape the virion glycome during
interspecies transmission of Semliki Forest virus.
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■ INTRODUCTION
Semliki Forest virus (SFV) is a prototypic alphavirus within the
Togaviridae family and was ﬁrst isolated in Aedes albopictus
mosquitoes in Uganda in 1944.1 Although SFV infection only
causes mild febrile illness in humans, it is highly pathogenic in
rodents and has become a model system for investigating viral
encephalitis2 caused by other neurotropic alphaviruses such as
Sindbis virus, Chikungunya virus (CHIKV), and Venezuelan
equine encephalitis virus.
The positive-sense, single-stranded RNA alphavirus genome
encodes nine proteins, three of which are structural and encoded
in the second of two open reading frames. In the mature particle,
the capsid protein C forms an icosahedral shell (triangulation T =
4) that encapsulates the viral RNA and is surrounded by a lipid
bilayer.3,4 Twomembrane-bound glycoproteins, E1 and E2, form
an outer icosahedral shell (triangulation T = 4)4,5 and are
responsible for host cell fusion and attachment, respectively.6 E1
and E2 are generated by proteolytic cleavage of polyprotein
precursor via the E1−p62 intermediate.7
Alphaviruses assemble in the plasma membrane, where the
cytoplasmic tail of the E2 glycoprotein interacts with the RNA-
containing capsid, leading to budding of mature virions.8 Co-
translational formation of the E1−p62 heterodimer is necessary
for proper folding.7 The E1−p62 heterodimer forms concom-
itantly to protein folding in the ER, and the glycans are initially
processed in the context of this structure.7 The initial formation
of single trimeric viral spikes, (E1−p62)3, is thought to occur in
this stage.9 Proteolytic cleavage by furin in the trans-Golgi
network is required to cleave p62 into E2 and a third
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glycoprotein, E3.10 This cleavage primes E1 for fusion and
enables the formation of trimers of E1/E2 heterodimers on
infectious virus particle.4
The E1 glycoprotein forms a class-II fusion glycoprotein fold11
with a sequence-internal hydrophobic fusion peptide that is
buried within the E1−E2 interface.12 Upon endosomal acid-
iﬁcation during clathrin-mediated host cell entry, E1 undergoes
conformational rearrangements into fusogenic homotrimers,
which merge the virion and endosomal membranes.13−15 The
structure of the E2 glycoprotein was revealed through crystallo-
graphic analysis of the E1−E2 complex from CHIKV.12 E2 is
composed of three immunoglobulin-like domains and forms a
∼2500 Å2 protein−protein contact surface with E1.12,16
Infectious particles are targeted by the host antibody response,
which is directed predominantly to E2.17 This is consistent with
E2 being more membrane distal and solvent-exposed than
E1.12,18−20 The capacity of alphaviruses to infect a wide range of
species is suggested to be, in large part, due to the ability of the E2
glycoprotein to attach to and interact with multiple cellular
receptors.21
Alphaviral glycosylation is an important determinant of
cellular tropism and virulence,22−25 and the composition of
alphavirion glycans derived from mammalian cell lines has been
the subject of extensive study.26−36 The alphaviral E1 and E2
glycoproteins are post-translationally modiﬁed with N-linked
glycosylation. For example, SFV has one N-linked sequon on E1
and two on E2.37 Across alphaviruses, it has been generally
observed that glycans from the E1 fusion glycoprotein derived
frommammalian cell lines are highly processed and composed of
complex-type glycosylation. Conversely, glycans from the E2
glycoprotein exhibit endoglycosidase H (EndoH) sensitivity and
are, therefore, composed of hybrid- or oligomannose-type
structures. For example, across the eastern equine encephalitis
alphaviruses, E1 exhibits complex-type glycosylation, while E2
has a high level of Endo H-sensitive structures.32 Similarly,
Barmah Forest virus exhibits predominantly complex-type
glycosylation on E1 but has no glycans on E2.29,30 In Sindbis
virus, E1 primarily exhibited complex-type glycosylation, while
E2 exhibited a greater degree of oligomannose-type glycosyla-
tion.31,36 Importantly, the location of the N-linked glycan
sequons is not well-conserved across the alphaviruses, and the
precise environment of a glycan can heavily inﬂuence
processing.38
The identiﬁcation of less-processed structures has implicated
C-type lectins, DC-SIGN and L-SIGN, as putative mammalian
attachment receptors for alphaviruses.22 Host species have a
signiﬁcant impact on glycosylation processing, however, which
may introduce or eliminate these lectin-binding motifs.39 For
example, SFV derived from mosquito C6/36 cells exhibited
Endo D-sensitive paucimannose structures on E1, while E2 was
almost entirely sensitive to Endo H.24,26 The formation of
paucimannose structures necessitates extensive Golgi-mediated
processing for biosynthesis.33,34 These structures are therefore
biosynthetically analogous to the processed complex-type
glycosylation of mammals.
It has been long appreciated that both cellular (e.g., cell type)
and viral factors (e.g., protein-directed glycosylation) play an
important role in determining the chemical composition of
glycans.24,38,40 We selected the prototypic alphavirus, SFV, to
investigate the compositional variation of glycosylation through a
side-by-side comparison of virus derived from both arthropod
and rodent cell lines. We performed mass spectrometric analysis
of the glycans from SFV puriﬁed from both types of cell lines
using ion-mobility mass spectrometry and collision-induced
dissociation analysis. We observe that in contrast with the fully
processed E1 glycoprotein, E2 preserves under-processed
oligomannose-type structures regardless of host species. By
integrating this analysis with known crystallographic and electron
microscopy data, we rationalize these observations and propose
that glycan processing on E2 is restrained by local steric-
hindrance, whereas the E1 glycan is accessible to enzymes despite
being located at the base of the multimeric viral spike. Our mass
spectrometric study comprises the ﬁrst structural and composi-
tional analysis of alphavirus N-linked glycosylation. These data
reveal the consequence of steric protection and cellular
processing enzymes on the composition of the virion glycome
during interspecies transmission of SFV.
■ MATERIAL AND METHODS
Virus Preparation
BHK-21 (baby hamster kidney-21) cells were maintained in
Glasgow minimal essential medium supplemented with 10%
tryptose phosphate broth and 5% fetal bovine serum (FBS) at 37
°C in a humidiﬁed atmosphere containing 5% CO2. C6/36 cells
were maintained in Schneider’s Drosophila medium supple-
mented with 10% FBS and 2% glutamine and grown at 28 °C in a
humidiﬁed atmosphere containing 5% CO2.
Wild-type SFV (strain pSP6-SFV4)41 was kindly provided by
Prof. M. Kielian (Albert Einstein College of Medicine, NY) and
propagated in BHK-21 cells to determine virus titer. C6/36 cells
and BHK-21 were infected at a multiplicity of infection of 1 and
0.1, respectively. Media containing secreted SFV were collected
∼136 h following infection in C6/36 cells and ∼22 h after
infection in BHK-21 cells, similar to previous methods.42 Virion
puriﬁcation was based on that previously described for
alphaviruses.43 Supernatants were cleared from cell debris by
low-speed centrifugation, and viral particles were pelleted by
ultracentrifugation. For SFV isolation from BHK-21 cells, an
additional sucrose density gradient centrifugation step was
added. Virus purity and endoglycosidase F1 (Endo F1)
susceptibility was conﬁrmed by SDS-PAGE analysis. Endo F1
was expressed as a fusion protein with glutathione S-transferase
(GST) and has been previously described by Grueninger-Leitch
et al.44
Electron Microscopy
To conﬁrm sample integrity, we vitriﬁed puriﬁed SFV from BHK
cells by rapid plunge-freezing on “C-ﬂat” electron microscopy
grids (Protochips, Raleigh, NC) into a mixture of liquid ethane
(37%) and propane (63%).45 Electron cryomicroscopy was
performed using a 300 kV “Polara” transmission electron
microscope (FEI, Eindhoven, Netherlands) operated at a
temperature of ∼80 K. Images of SFV were taken at −4 μm
defocus using a charge-coupled device camera (Ultrascan
4000SP; Gatan, Pleasanton, CA) at a nominal magniﬁcation of
×93 000, corresponding to a calibrated pixel size of 0.24 nm with
a dose of ∼12 e−/Å2.
Glycan Isolation
Oligosaccharides were released from SFV E1 and E2
glycoproteins with peptide-N-glycosidase F (New England
Biolabs, Ipswich, MA) from Coomassie blue-stained PAGE
gels, as previously described.46 Gel bands were excised, washed
ﬁve times alternatively with acetonitrile and deionized water, and
rehydrated with 30 units of aqueous PNGase F solution. After
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incubation for 12 h at 37 °C, enzymatically released glycans were
eluted with water.
Ion-Mobility Mass Spectrometry
Glycan samples were diluted with 5 μL of water. A 1 μL aliquot
was cleaned with a Naﬁonmembrane47 and diluted with water (4
μL), methanol (5 μL), and 0.1 M ammonium phosphate (0.5 μL,
to maximize formation of [M+H2PO4]
− ions) and centrifuged at
9500g for 1 min. Electrospray (ESI) and ion mobility
experiments were carried out in negative ion mode with a
Waters Synapt G2 traveling wave ionmobility mass spectrometer
(Waters MS-technologies, Manchester, U.K.)48 ﬁtted with an
ESI ion source. Samples were infused through Waters thin-wall
nanospray capillaries. The ESI capillary voltage was 1.2 kV, the
cone voltage was 80 V, and the ion source temperature was
maintained at 80 °C. The T-wave velocity and peak height
voltages were 450 m/sec and 40 V, respectively. Instrument
calibration was performed with released N-linked glycans from
bovine fetuin. The T-wave mobility cell (nitrogen) was operated
at a pressure of 0.55 mbar. Fragmentation was performed after
mobility separation in the transfer cell with argon as the collision
gas. Data acquisition and processing were carried out using the
Waters Driftscope (version 2.1) software andMassLynx (version
4.1). Analysis of MS data was performed using the previously
described methods49−51 by comparison with spectra of well-
characterized N-linked glycans from ribonuclease B,52 bovine
fetuin,53 and human transferrin.54
Model Construction
A model of N-linked glycan presentation on the alphavirus
surface was created using the crystal structure of the CHIKV E1−
E2 envelope glycoprotein complex ﬁt into the Sindbis virus cryo-
EM map (PDB accession number 2XFB12). N-linked glycans,
representative of those observed on SFV when produced in BHK
and C6/36 cells (see Results and Discussion), were modeled
onto the N-linked carbohydrate attachment sites Asn141 on E1
as well as Asn200 and Asn262 on E2. Figures were illustrated
using PyMol (www.pymol.org).
Nomenclature
The symbolic representation of glycans follows that of Harvey et
al.55 with residues in both the schematic diagrams and molecular
graphics following the color scheme of the Centre for Functional
Glycomics, as previously implemented.56,57 A key is given in
Figure 2. Thus, ions retaining charge on the nonreducing
terminus are named “A” (cross-ring), “B”, and “C” (glycosidic)
with corresponding ions from the reducing terminus named X, Y,
and Z. Subscript numbers deﬁne the bonds cleaved in the glycan
sequence. For fragmentation analysis, we applied an extension of
the Domon and Costello nomenclature by Harvey et al.,58,59
whereby the subscript number for the reducing terminal GlcNAc
residue is replaced by “R” and the number from the adjacent
GlcNAc is replaced by “R-1”. This nomenclature describes
fragmentations of diﬀerent glycan cores to avoid confusion by the
subscript number changing in response to diﬀerent antenna
lengths. Bonds cleaved in the cross-ring cleavage reactions are
indicated by superscript numbers.
■ RESULTS AND DISCUSSION
The glycosylation of alphavirus has been extensively studied, and
the SFV E1 and E2 glycoproteins have been shown to exhibit
diﬀering degrees of biosynthetic processing of N-linked glycans.
However, the composition of these glycans, including that arising
from diﬀerent host cells, has not been determined. We have
applied ion-mobility mass spectrometry to deﬁne the virion
glycome in two principal host species, rodent and mosquito.
Preparation of Rodent and Mosquito SFV Glycoforms
For virus propagation and puriﬁcation, BHK and mosquito C6/
36 cells were infected with SFV. These cell lines were chosen
because the natural hosts of SFV include mosquitoes and
rodents.1,2,60 To purify and isolate virions, we subjected media
from infected cells to ultracentrifugation. We veriﬁed that our
production and puriﬁcation system was generating mature intact
particles by electronmicroscopy and SDS-PAGE analysis (Figure
1). The electronmicrographs revealed uniform virions consistent
with theirT = 4 icosahedral symmetry11 (Figure 1A). SDS-PAGE
analysis revealed three discrete bands consistent with E1, E2, and
the capsid protein (Figure 1B).
E1 and E2 Diﬀer in Sensitivity to Endoglycosidase F1
Following previous investigations of alphaviral glycosyla-
tion,26−36 we studied the sensitivity of the virion-associated E1
and E2 glycans to Endo F1 digestion (Figure 1B). The Endo F1
used in this study has been previously described by Grueninger-
Leitch et al.44 Endo F1 hydrolyzes the di-N-acetylchitobiose core
(GlcNAcβ1→4GlcNAc) of oligomannose-type and hybrid-type
glycans.61 Complex-type glycans are insensitive to Endo F1.
61 E1,
regardless of being derived from BHK or C6/36 cells, was largely
insensitive to Endo F1 (Figure 1B) and is therefore largely devoid
of oligomannose- and hybrid-type glycosylation. In contrast, E2
exhibited a reduction in apparent molecular mass by several
Figure 1. Sample preparation of SFV from BHK and C6/36 cell lines. (A) Electron cryomicroscopy image of SFV virions, puriﬁed fromBHK cells, taken
at −4 μm defocus. Scale bar: 50 nm. (B) SDS-PAGE analysis of SFV puriﬁed from BHK (lanes 1 and 2) and C6/36 cells (lanes 3 and 4). The gel was
stained with Coomassie blue, and the protein bands correspond to the SFV structural proteins: capsid (labeled “C”; white triangle), E1 (gray triangle),
and E2 (black triangle) proteins. BHK- and C6/36-derived SFVwere treated with endoglycosidase F1 (Endo F1; star) in lanes 2 and 4, respectively. Endo
F1 was expressed as a fusion protein with GST, as previously reported.
44
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kilodaltons (Figure 1B), indicating the presence of oligoman-
nose- or hybrid-type glycan structures. These results are
consistent with the role of E2 in C-type lectin binding22 as well
as with previously described radiolabeling experiments, which
revealed diﬀerential processing of E1 and E2 in C6/36 cells.26
While E2 from both cell lines migrated similarly, E1 from BHK
cells was measurably larger in apparent molecular mass than E1
from C6/36 cells (Figure 1B). These results suggest that N-
linked post-translational modiﬁcations are more substantial in
BHK cells than in C6/36 cells. Our ﬁndings support the
conclusion that SFV exhibits glycosylation directed by viral and
cellular factors on E2 and E1 glycoproteins, respectively.
Analysis of N-Linked Glycans from Intact Virions by Ion
Mobility MS
To identify the chemical composition of the N-linked glycans
from E1 and E2 of SFV, we performed mass spectrometric
analysis of enzymatically released glycans. Because low-
abundance biological samples often pose challenges to detailed
characterization,51 we chose to employ ion mobility MS. This
technique enables the separation of glycan ions that are otherwise
obscured by contamination arising during sample preparation.51
We hypothesized that this method would enable analysis of
glycans from intact virions at suﬃcient signal-to-noise ratio,
which hitherto has been limited.
For ion mobility MS, E1 and E2 glycans from both C6/36 and
BHK cells were released by PNGase F exoglycosidase treatment.
This treatment releases all N-linked glycans except for those with
core α1→3-fucosylation.62 The resulting spectra of the extracted
glycans from E1 and E2 are shown in Figures 2 and 3,
respectively, and reveal the utility of ionmobilityMS for studying
low abundance samples.
Cell-Line-Dependent Processing of E1
Consistent with the protein migration shift observed in Figure
1B, ion mobility MS revealed that the molecular mass of E1
glycans produced in the rodent cells (BHK) was considerably
larger than E1 glycans produced in the mosquito cells (C6/36)
(Figure 2). The spectrum of mosquito cell-derived E1 glycans
was dominated by paucimannose structures and minor
fucosylated derivates , such as Man3GlcNAc2 and
Man3GlcNAc2Fuc, respectively (Figure 2A). This is consistent
with extensive glycan processing in the mosquito Golgi
apparatus.63 In this insect system, glycans are trapped in the
Figure 2.Mobility-extracted singly negatively charged N-glycan ions from the E1 glycoproteins from the mosquito (spectrum A) and rodent cell lines
(spectrum B). A key to the symbols used for the glycan structures is displayed in the upper right-hand corner of panel A. The linkages are shown by the
angle of the lines connecting the symbols (| = 2-link, / = 3-link,− = 4-link, and \ = 6-link). α-Bonds are shown with broken lines and β-bonds are shown
with full lines. Full details are given in ref 79. Oligomannose-type glycans are highlighted in green, and fragment ions are shown in gray.
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paucimannose state by hexosaminidase activity, which removes
the GnT I-mediated GlcNAc necessary for the action of other
transferases.63 In contrast, the spectrum of E1 glycans derived
from the rodent cell line exhibited considerable complexity,
dominated by biantennary glycans exhibiting variable occupancy
of terminal galactose and sialic acid (Figure 2B). This
observation supports a model whereby the E1 glycan is fully
accessible to enzymatic processing. Hybrid-type glycans are also
present together with a minor population of smaller
oligomannose-type glycans. Importantly, the relative population
of oligomannose-type glycans matched that observed in the
spectrum of mosquito-derived E1 with Man5GlcNAc2 >
Man6GlcNAc2 > Man7GlcNAc2. This comparable distribution
is suggestive of conserved processing between systems. We
suggest this is likely to arise from similar glycan presentation and
accessibility to biosynthetic enzymes in the ER.
Virion-Directed Glycosylation of E2
Comparison of the spectra of E2 glycans from mosquito and
rodent cell lines revealed substantial convergence of composition
despite the considerable variation in the processing machinery of
the two systems (Figure 3). Both spectra were dominated by the
full oligomannose series, Man5−9GlcNAc2, with only a minor
population of glycans exhibiting Golgi processing, characteristic
of that primarily observed on E1 glycans. In contrast with the
conserved distribution of oligomannose-type structures in E1
(Figure 3), the distribution of oligomannose-type structures
diﬀered between rodent and mosquito-derived E2. In mosquito-
derived E2, the Man9GlcNAc2 glycan was most abundant with
decreasing levels down the series to Man5GlcNAc2. Surprisingly,
this trend was reversed in the rodent system. This reversal
indicates that while E2 glycans are largely protected from
processing following the calnexin/calreticulin folding check-
point, the eﬃcacy of the mosquito α-mannosidases diﬀers from
that of the rodent system. We would not expect the physical
presentation of these conserved, early glycans to diﬀer between
systems, and these diﬀerences are therefore likely driven by
dissimilarities in speciﬁc activity of cell resident α-mannosidases
or in transit time. The variance in E2 oligomannose processing
between cell lines may also indicate that the conservation of the
processing of the minor oligomannose series observed on E1 is
somewhat coincidental. Given the functional importance of
oligomannose-type glycans,22 it would be valuable to investigate
the stability of α-mannosidase processing in related alphaviruses.
It should also be noted that the temperature diﬀerence between
insect and mammalian viral production can inﬂuence viral
architecture, and this may inﬂuence glycan processing.64,65
Finally, E3 is shed in various stages during alphavirus biogenesis,4
and the inﬂuence of E3 on glycan processing is unknown.
Glycan Assignments by MS/MS
Ion mobility combined with MS/MS analysis involves a highly
sensitive ion-extraction technique, able to separate low
abundance glycan ions from contaminants, with the generation
of fragmentation ﬁngerprints characteristic of particular
substructures within glycans. This also enables accurate assign-
ments of isomers, for example, the eﬀective discrimination
between isobaric complex and hybrid-type structures on the
virion surface.
Figure 3.Mobility-extracted singly negatively charged N-glycan ions from the E2 glycoproteins from the mosquito (spectrum A) and rodent cell lines
(spectrum B). Symbols used for the glycan structures are as deﬁned in Figure 2. Oligomannose-type glycans are highlighted in green, and fragment ions
are shown in gray.
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The glycan assignments previously discussed were based on
detailed MS/MS fragmentation analysis following mobility
separation (Figures 4 and 5). The mass of each glycan gave the
constituent monosaccharide composition in terms of isobaric
residues such as hexose and N-acetylhexose (HexNAc).
Structures of the di-N-acetylchitobiose core, the 6- and 3-
antennae, isomers (when present), and the complex biantennary
glycans were assigned based on combination of the parent
molecular ion mass and the pattern of fragmentation ions
produced by collision-induced dissociation. This assignment
process is described later.
The di-N-acetylchitobiose core region of all glycans was
characterized by the production of abundant 2,4AR, BR‑1, and
2,4AR‑1 ions. (See the Nomenclature section.) For example, these
ions correspond to peaks at m/z 1072, 1012, and 869 in the
spectrum of Man5GlcNAc2 (Figure 5A). The phosphate adducts
of the glycans resulted in the 2,4AR ion appearing at 259 mass
units below that of the molecular ([M+H2PO4]
−) ion. A loss of
405 mass units, as observed in the spectrum of the fucose-
containing Man3GlcNAc2Fuc1 (Figure 4D), reveals that the
fucose is located at the six-position of the reducing-terminal
GlcNAc. (Note that the proton from the 3-OH group is lost
when forming this ion, leaving the six-position as the only
remaining position for substitution.) Figure 4C shows the
spectrum of the corresponding unfucosylated glycan.
The composition of the 6-antenna, and by diﬀerence the 3-
antenna, was deﬁned by analysis of the D and D-18 ions (these
ions are formed by the formal loss of the di-N-acetylchitobiose
core 3-antenna) and 0,3AR‑2 and
0,4AR‑2 ions from the core
branching mannose residue. These ions appear at m/z 647, 629,
575, and 545, respectively, in Man5GlcNAc2 (Figure 5A) and at
m/z 809, 791, 737, and 707 in that of Man8GlcNAc2 (Figure 4A),
where there is an additional mannose residue in the 6-antenna.
Localization of this mannose to the 6-branch of this antenna was
facilitated by identiﬁcation of the abundant ion at m/z 485,
termed D′. Where isomers were present, as in the case of
Man7GlcNAc2 (Figure 4B), two groups of ions appeared
depending on the number of mannose residues in the 6-antenna.
In this spectrum, ions at m/z 647, 629, and 545 and at m/z 809,
791, 737, and 707, respectively, revealed the presence of three
and four mannose residues in the 6-antenna. The presence of
these ions also informed on the composition of hybrid-type
glycans in the BHK-derived samples (Figure 5B,C). For example,
ions at m/z 647, 629, 575, and 545 in the spectrum of
Man5Gal1GlcNAc3 (Figure 5B) revealed glycans at the 6-antenna
identical to those observed in the high-mannose glycan,
Man5GlcNAc2 (Figure 5A). An additional feature of hybrid-
Figure 4. Examples of mobility-extracted, negative ion CID (transfer region) spectra of N-glycans from SFV derived from a mosquito cell line. (A)
Man8GlcNAc2, (B) Man7GlcNAc2, (C) Man3GlcNAc2, and (D) fucosylated Man3GlcNAc2. Symbols used for the glycan structures are as deﬁned in
Figure 2. Ion nomenclature follows that proposed by Domon and Costello58 with spectral interpretation as described by Harvey et al.49,50
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type glycans (Figure 5B,C) is the presence of the 1,3A3 ion atm/z
424, which deﬁnes a Gal-GlcNAc composition at the 3-antenna.
The single C1 ion atm/z 179 in the glycoforms derived from both
C6/36 and BHK cells (Figures 4 and 5) conﬁrms hexose as the
terminating residue for all antennae.
Structures of the complex biantennary glycans, such as those
depicted in Figure 5C,D, were similarly determined by
characteristic fragmentation ions. D and D-18 ions were located
atm/z 688 and 670, respectively, while the single 1,3A3 ion atm/z
424 conﬁrmed the structure of the Gal-GlcNAc antennae.
Termination of these fragments with galactose is supported by
identiﬁcation of the C1 ion atm/z 179. Substitution of this glycan
with sialic acid (Figure 5D) gave a spectrum similar to that of the
neutral glycan. The 2,4AR, BR‑1, and
2,4AR‑1 ions were formed with
concomitant loss of the sialic acid moiety, and their mass at m/z
1478, 1418, and 1275 conﬁrmed the presence of the core fucose.
Conﬁrmation of the sialic acid (Neu5Ac) residue was made by
the B1 ion at m/z 290, and the absence of the ion at m/z 306
showed that this residue was predominantly α2→3 linked.66
Distribution of Glycans Across the Alphaviral Surface
Our analysis supports the conclusion that the glycans of the E2
glycoprotein are largely resistant to enzymatic processing. There
are many examples where the local environment of glycans limits
processing in the ER and Golgi apparatus in both mammalian
and viral glycoproteins.38 One extreme example is the processing
of the envelope attachment glycoprotein gp120 from the human
immunodeﬁciency virus (HIV-1).67 The density of N-linked
glycans is suﬃcient to induce a minimally processed “mannose
patch” of oligomannose-type glycans on intact virions.68−70
More commonly, protein−carbohydrate packing can also disrupt
the processing of N-linked glycosylation.38,71,72
The presence of oligomannose-type glycans on SFV can
inﬂuence cellular tropism and virulence24 and suggests that there
may have been evolutionary pressure on the virus to control the
processing of host glycosylation by indirectly altering the
proteinous environment around the glycans. When considering
the structural inﬂuences on glycan processing, it is important to
evaluate the presentation of glycans to α-mannosidases both
from initial folding in the ER and Golgi transit. In SFV
biosynthesis, initially isolated E1−p62 heterodimers are formed
in the ER and are then thought to trimerize.7 The trimers are
transported from the ER to the Golgi apparatus and further
toward the plasma membrane. During later stages of transport,
(E1−p62)3 complexes are thought to form higher order
assemblies similar to those observed in the virion.9
To rationalize the structure of the glycans on the mature virion
surface, we constructed a model of the mature (E1−E2)3 viral
spike from the structure of the related alphaviral CHIKV
glycoproteins. Glycans were modeled onto the E1 and E2
glycoprotein using the crystallographic coordinates reported for
Figure 5. Examples of mobility-extracted, negative ion CID (transfer region) spectra of N-glycans from SFV derived from rodent cell lines. (A)
Man5GlcNAc2, (B) hybrid-type glycan (Man5GlcNAc3Gal1), (C) biantennary glycan (Man3GlcNAc4Gal2), and (D) sialylated biantennary glycan
(Man3GlcNAc4Gal2Fuc1Neu5Ac1).
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a sialylated complex-type glycan73 and an oligomannose-type
glycan,74 respectively. A model for the virion surface was further
constructed by using the glycosylated CHIKV E1−E2 structure
ﬁtted into the electron microscopy map of Sindbis virus12 for
SFV produced in both rodent (Figure 6A) and mosquito (Figure
6B) cells.
Despite being located in the crevices created by the virion
spike, the E1 glycan is fully accessible both in isolated (E1−E2)3
complexes, which are likely to be observed in the Golgi apparatus
Figure 6.Models of the glycosylated alphavirus surface as derived from rodent (A) and mosquito (B) cells. The crystal structure of the CHKV E1−E2
envelope glycoprotein complex was ﬁtted into the Sindbis virus cryo-EM map (PDB accession number 2XFB).12 E1 and E2 are shown in a surface
representation in dark gray and light gray, respectively. Oligomannose-type glycans, presented by E2 at Asn200 and Asn262, are shown as light- and
dark-green spheres, respectively (Man9GlcNAc2, from PDB accession code 2WAH
74). At Asn141, glycan structures are modeled as complex-type
glycans for rodent-derived alphavirus (panel A; pink spheres, from PDB accession code 4BYH73) and paucimannose-type for mosquito-derived
alphavirus (panel B; orange spheres, from PDB accession code 2WAH).
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and ER, and in the mature virion through the hexagonal space
formed between protomers (Figure 6). This presentation is
entirely consistent with host-dependent glycosylation in rodent
(Figure 6A) and mosquito (Figure 6B) cellular secretion
pathways, whereby glycosylhydrolases and glycosyltransferases
help to determine glycan composition. In contrast with E1, the
E2 glycans are more membrane-distal and are located on the side
of the viral spike, which is presumably suﬃcient to limit α-
mannosidase processing in the ER and early Golgi (Figure 6). In
the mature virion, the glycans are driven into close proximity to
the protein surface of opposing protomers of the trimer and yet
are accessible for cell attachment by DC-SIGN recognition.22
■ CONCLUSIONS
Our study provides a glycomic analysis of the N-linked glycans
displayed on the major glycoproteins from SFV, a prototypic
alphavirus. Consistent with early electrophoretic analyses of
alphaviral glycans,26−36 we show that E1 and E2 display
predominantly complex- and oligomannose-type glycosylation,
respectively. These results indicate that in contrast with E1,
which presents glycans characteristic of the host species, the
glycan processing of E2 is particularly restricted. Such composi-
tional diﬀerences may be attributed to localized steric-controlled
hindrance of enzymatic processing imposed by the virus.
The presence of both complex- and oligomannose-type
glycosylation on the envelope glycoproteins of membranous
viruses is an emerging theme in viral glycomics. As an extreme,
the oligomannose-type glycans on gp12068 of HIV-1 are thought
to arise by local steric constraints imposed by both glycan−
glycan clustering and glycan−protein interactions.69 Similar to
SFV,22−25 precise glycan processing inﬂuences the cellular
tropism of HIV-1.75 In addition, broadly neutralizing antibodies
that recognize mixed glycan/protein epitopes have emerged as
guides to HIV vaccine design and even as potential
antivirals.76−78 To this end, our analysis of SFV virion
glycosylation assists in the deﬁnition of the alphaviral antigenic
surface. Deﬁning how the host modulates alphavirion glyco-
sylation will assist in understanding how themammalian immune
system diﬀers in the recognition of insect- and mammalian-
derived particles.
We anticipate that the sensitive ion mobility methodologies
adopted in this study will enable the precise analysis of glycans
from membrane viruses where low abundance has impeded
traditional mass spectrometric approaches. The resolution of our
method further allows us to explore the range of structures
displayed by each of the alphaviral glycoproteins. We show that
speciﬁc glycan types are not exclusive to either glycoprotein and
observe that both proteins display a full range of glycan
structures, ranging from oligomannose series with little
biosynthetic processing to fully processed complex-type glycans.
Such compositional variation, which is either imposed by the
virus or the host, is likely to inﬂuence host-cell tropism and
immunological responses to alphavirus infection.
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